Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-8,648
Closed -$434K 531
2017
Q1
$434K Buy
8,648
+188
+2% +$9.16K 0.06% 213
2016
Q4
$419K Buy
8,460
+3,120
+58% +$158K 0.06% 225
2016
Q3
$280K Buy
+5,340
New +$262K 0.04% 371
2015
Q3
Sell
-16,936
Closed -$628K 566
2015
Q2
$628K Buy
16,936
+50
+0.3% +$1.82K 0.09% 153
2015
Q1
$591K Buy
16,886
+54
+0.3% +$1.91K 0.07% 172
2014
Q4
$641K Buy
16,832
+6,383
+61% +$233K 0.09% 128
2014
Q3
$371K Buy
+10,449
New +$388K 0.08% 195

Other funds holding XYL

Parkwood LLC's XYL Position: Q2 2017 in Review

Parkwood LLC sold out of Xylem (XYL) in Q2 2017, closing a stake of 8,648 shares — an estimated $434K sold.

Parkwood LLC first reported a position in XYL in Q3 2014 and held it in 7 quarters. The position peaked at $641K in Q4 2014. 550 funds tracked by Wall St. Rank hold XYL as of Q2 2017.

  • Parkwood LLC reported no remaining Xylem position as of Q2 2017 after selling out during the quarter.
  • Parkwood LLC sold 8,648 Xylem shares in Q2 2017, an estimated $434K.
  • Parkwood LLC first reported a position in Xylem in Q3 2014 and held it in 7 quarters.
  • Parkwood LLC's Xylem position peaked at $641K in Q4 2014.
  • 550 funds tracked by Wall St. Rank held Xylem as of Q2 2017.

Based on Parkwood LLC's 13F filing for Q2 2017, filed 25 Jul 2017.